It was demonstrated that CSCs isolated from gemcitabine-resistant pancreatic cancer release vesicles that can stimulate the expression of drug-resistance-related proteins, such as P-gp, Y-box binding protein 1, and breast cancer resistance protein, in a drug-sensitive pancreatic cancer cell line [104]. The gene discussed is PGP; the disease is familial pancreatic carcinoma.